Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial

AstraZeneca1,950 enrolled

Overview

Purpose of this study is the evaluation of QoL, tolerability and use of Zoladex 10,8 SafeSystem for advanced PCa under naturalistic conditions

Study Type

OBSERVATIONAL

Enrollment

1,950

Sex: MALE

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with PCa, who will be treated with Zoladex 10,8 SafeSystem based on the current SPC

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.